Literature DB >> 19683632

Insulin glargine and cancer: another side to the story?

Edwin A M Gale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19683632     DOI： 10.1016/S0140-6736(09)61477-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Insulin glargine and incidence of cancer--an ongoing debate.

Authors:  Norbert Hermanns; Bernd Kulzer
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

2.  Uncertain risks of drug related harms, the precautionary principle and limitations of meta-analysis.

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2009-11       Impact factor: 4.335

Review 3.  Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence.

Authors:  J A Johnson; B Carstensen; D Witte; S L Bowker; L Lipscombe; A G Renehan
Journal:  Diabetologia       Date:  2012-04-04       Impact factor: 10.122

4.  Protected graft copolymer (PGC) basal formulation of insulin as potentially safer alternative to Lantus® (insulin-glargine): a streptozotocin-induced, diabetic Sprague Dawley rats study.

Authors:  Sandra Reichstetter; Gerardo M Castillo; ManShun Lai; Akiko Nishimoto-Ashfield; Aryamitra Banerjee; Alexei Bogdanov; Alexander V Lyubimov; Elijah M Bolotin
Journal:  Pharm Res       Date:  2011-12-28       Impact factor: 4.200

Review 5.  Metformin--mode of action and clinical implications for diabetes and cancer.

Authors:  Ida Pernicova; Márta Korbonits
Journal:  Nat Rev Endocrinol       Date:  2014-01-07       Impact factor: 43.330

Review 6.  The insulin and insulin-like growth factor receptor family in neoplasia: an update.

Authors:  Michael Pollak
Journal:  Nat Rev Cancer       Date:  2012-02-16       Impact factor: 60.716

7.  Impact of Insulin Therapies on Cancer Incidence in Type 1 and Type 2 Diabetes: A Population-Based Cohort Study in Reggio Emilia, Italy.

Authors:  Massimo Vicentini; Paola Ballotari; Francesco Venturelli; Marta Ottone; Valeria Manicardi; Marco Gallo; Marina Greci; Mirco Pinotti; Annamaria Pezzarossi; Paolo Giorgi Rossi
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

8.  Diabetes, insulin treatment, and cancer risk: what is the evidence?

Authors:  Madona Azar; Timothy J Lyons
Journal:  F1000 Med Rep       Date:  2010-01-18

9.  Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study.

Authors:  Anna But; Marie L De Bruin; Marloes T Bazelier; Vidar Hjellvik; Morten Andersen; Anssi Auvinen; Jakob Starup-Linde; Marjanka K Schmidt; Kari Furu; Frank de Vries; Øystein Karlstad; Nils Ekström; Jari Haukka
Journal:  Diabetologia       Date:  2017-06-01       Impact factor: 10.122

Review 10.  Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.

Authors:  Oystein Karlstad; Jacob Starup-Linde; Peter Vestergaard; Vidar Hjellvik; Marloes T Bazelier; Marjanka K Schmidt; Morten Andersen; Anssi Auvinen; Jari Haukka; Kari Furu; Frank de Vries; Marie L De Bruin
Journal:  Curr Drug Saf       Date:  2013-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.